Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Heparin for Moderately Ill Patients with Covid-19

Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed Alsheef, Fahad AlSumait, Carlos Eduardo Pompilio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana Castellucci, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Christos Colovos, Jai Jayakar, Marie-Pier Arsenault, Cynthia Wu, Karine Doyon, E. Roseann Andreou, Vera Dounaevskaia, Eric K. Tseng, Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Y.Y. Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni, the RAPID Trial investigators
doi: https://doi.org/10.1101/2021.07.08.21259351
Michelle Sholzberg
1Departments of Medicine, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada
MDCM MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michelle.sholzberg@unityhealth.to
Grace H. Tang
2Hematology-Oncology Clinical Research Group, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hassan Rahhal
3Disciplina de Emergencias Clinicas, Departamento de Clinica Medica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, BR
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Musaad AlHamzah
4Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division of Vascular Surgery, King Saud University Medical City, Riyadh, Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Baumann Kreuziger
5Versiti, Medical College of Wisconsin, Milwaukee, WI, USA
MD MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fionnuala Ní Áinle
6Mater Misericordiae University Hospital, Dublin, Ireland; School of Medicine, University College Dublin; Irish Network for Venous Thromboembolism Research
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faris Alomran
7Department of Vascular Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalid Alayed
8Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Alsheef
9Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fahad AlSumait
10Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Eduardo Pompilio
11Carlos Eduardo Pompilio MD PhD – Disciplina de Clinica Geral e Propedeutica, Departamento de Clinica Medica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, BR
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Sperlich
12Hôpital Charles-Lemoyne, CISSS de la Montérégie-Centre, Université de Sherbrooke, Greenfield Park, Québec, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrena Tangri
13Department of Medicine, William Osler Health System, Brampton, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terence Tang
14Institute for Better Health, Trillium Health Partners, Department of Medicine, University of Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Jaksa
15St. Joseph’s Health Centre, Unity Health Toronto, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepa Suryanarayan
16Department of Medicine, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mozah Almarshoodi
17Tawam Hospital, SEHA, AlAin, United Arab Emirates
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lana Castellucci
18Department of Medicine, The Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula D. James
19Department of Medicine, Queen’s University, Kingston, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lillicrap
20Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Carrier
21Department of Medicine, The Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Beckett
22St. Michael’s Hospital, University of Toronto, Toronto, Canada, Canadian Forces Health Services, Ottawa, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Colovos
23Division of Acute Care Surgery, Department of Surgery, University of Vermont Medical Center; University of Vermont Larner College of Medicine, Burlington, VT USA
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jai Jayakar
24Southlake Regional Health Centre, University of Toronto, Newmarket, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Pier Arsenault
25Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia Wu
26University of Alberta Hospital, University of Alberta, Edmonton, Alberta, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karine Doyon
27Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Quebec, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Roseann Andreou
28Michael Garron Hospital, University of Toronto, Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vera Dounaevskaia
29St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric K. Tseng
30St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
MD MScCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gloria Lim
31St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Fralick
32General Internal Medicine, Sinai Health, University of Toronto, Toronto, Ontario, Canada
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saskia Middeldorp
33Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnes Y.Y. Lee
34Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Zuo
35Applied Health Research Centre (AHRC), Unity Health Toronto (St. Michael’s Hospital), Toronto, Ontario, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno R. da Costa
36Applied Health Research Centre (AHRC), St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada, Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin E. Thorpe
37Dalla Lana School of Public Health, University of Toronto, Applied Health Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada
MMath
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elnara Márcia Negri
38Laboratorio de Investigaçao Medica LIM-59, Biologia Celular, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, SP, BR
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Cushman
39Larner College of Medicine, University of Vermont. University of Vermont Medical Center, Burlington, USA
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Jüni
40St. Michael’s Hospital, Applied Health Research Centre, Li Ka Shing Knowledge Institute, Departments of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Heparin, in addition to its anticoagulant properties, has anti-inflammatory and potential anti-viral effects, and may improve endothelial function in patients with Covid-19. Early initiation of therapeutic heparin could decrease the thrombo-inflammatory process, and reduce the risk of critical illness or death.

Methods We randomly assigned moderately ill hospitalized ward patients admitted for Covid-19 with elevated D-dimer level to therapeutic or prophylactic heparin. The primary outcome was a composite of death, invasive mechanical ventilation, non-invasive mechanical ventilation or ICU admission. Safety outcomes included major bleeding. Analysis was by intention-to-treat.

Results At 28 days, the primary composite outcome occurred in 37 of 228 patients (16.2%) assigned to therapeutic heparin, and 52 of 237 patients (21.9%) assigned to prophylactic heparin (odds ratio, 0.69; 95% confidence interval [CI], 0.43 to 1.10; p=0.12). Four patients (1.8%) assigned to therapeutic heparin died compared with 18 patients (7.6%) assigned to prophylactic heparin (odds ratio, 0.22; 95%-CI, 0.07 to 0.65). The composite of all-cause mortality or any mechanical ventilation occurred in 23 (10.1%) in the therapeutic heparin group and 38 (16.0%) in the prophylactic heparin group (odds ratio, 0.59; 95%-CI, 0.34 to 1.02). Major bleeding occurred in 2 patients (0.9%) with therapeutic heparin and 4 patients (1.7%) with prophylactic heparin (odds ratio, 0.52; 95%-CI, 0.09 to 2.85).

Conclusions In moderately ill ward patients with Covid-19 and elevated D-dimer level, therapeutic heparin did not significantly reduce the primary outcome but decreased the odds of death at 28 days.

Trial registration numbers: NCT04362085; NCT04444700

Competing Interest Statement

Grant funding for research. All authors have completed the ICMJE uniform disclosure form. Dr. Michelle Sholzberg reports grants from the Task 54, Defence Research Development Canada, Department of National Defence, Ottawa, Canada, St. Michael's Hospital Foundation, Toronto, Canada, St. Joseph's Health Centre Foundation, Toronto, Canada, The Ottawa Hospital Foundation COVID-19 Emergency Response Fund, Ottawa, Canada, International Network of Venous Thromboembolism Clinical Research Networks (INVENT) Kickstarter Award, P20 GM135007 from the National Institute of General Medical Sciences, NIH, University of Vermont Medical Center Fund Grant, College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. Dr. Paula James reports funding from SEAMO (Southeastern Ontario Academic Medical Organization) COVID-19 Innovation Fund. Dr. Fionnuala Ní áinle reports funding from the Science Foundation Ireland (SFI; the Irish national foundation for investment in scientific and engineering research). Dr. E. Roseann Andreou reports funding from 2020 TD Community Health Solutions Fund COVID-19 Research Grant, Michael Garron Hospital, Toronto, Canada.

Clinical Trial

NCT04362085; NCT04444700

Clinical Protocols

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-021-05076-0

Funding Statement

The RAPID Trial was funded by: Task 54, Defence Research Development Canada, Department of National Defence, Ottawa, Canada, St. Michael's Hospital Foundation, Toronto, Canada, St. Joseph's Health Centre Foundation, Toronto, Canada, 2020 TD Community Health Solutions Fund COVID-19 Research Grant, Michael Garron Hospital, Toronto, Canada, The Ottawa Hospital Foundation COVID-19 Emergency Response Fund, Ottawa, Canada, International Network of Venous Thromboembolism Clinical Research Networks (INVENT) Kickstarter Award, Science Foundation Ireland, Enterprise Ireland, IDA Ireland COVID-19 Rapid Response Funding Call 20/COV/0157, Southeastern Ontario Academic Medical Organization (SEAMO) COVID-19 Innovation Fund, P20 GM135007 from the National Institute of General Medical Sciences, NIH, University of Vermont Medical Center Fund Grant, College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics and regulatory approval were obtained at each of the participating centres in the RAPID trial. Ethical oversight and approval for the entire study was provided by the institutional review boards of Clinical Trials Ontario - St. Michael's Hospital, Comissão Nacional de ética em Pesquisa, and Comitê de ética em Pesquisa.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Supplement converted to PDF.

Data Availability

Data may be available upon request in accordance with appropriate privacy and data sharing principles.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Heparin for Moderately Ill Patients with Covid-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Heparin for Moderately Ill Patients with Covid-19
Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed Alsheef, Fahad AlSumait, Carlos Eduardo Pompilio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana Castellucci, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Christos Colovos, Jai Jayakar, Marie-Pier Arsenault, Cynthia Wu, Karine Doyon, E. Roseann Andreou, Vera Dounaevskaia, Eric K. Tseng, Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Y.Y. Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni, the RAPID Trial investigators
medRxiv 2021.07.08.21259351; doi: https://doi.org/10.1101/2021.07.08.21259351
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Heparin for Moderately Ill Patients with Covid-19
Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed Alsheef, Fahad AlSumait, Carlos Eduardo Pompilio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana Castellucci, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Christos Colovos, Jai Jayakar, Marie-Pier Arsenault, Cynthia Wu, Karine Doyon, E. Roseann Andreou, Vera Dounaevskaia, Eric K. Tseng, Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Y.Y. Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni, the RAPID Trial investigators
medRxiv 2021.07.08.21259351; doi: https://doi.org/10.1101/2021.07.08.21259351

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)